Author

U. Hibner

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 4 Physiology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 5 Organism:mouse· 5 Research Focus:cancer & tumor microenvironment· 3 Research Focus:host-pathogen & immune response· 3 Assay:bulk RNA-seq· 2 Research Focus:cell signaling & trafficking· 2

Frequent Co-Authors

D. Gregoire· 4 shared G. Desandre· 3 shared J. Ursic-Bedoya· 3 shared A. Lozano· 2 shared C. Chavey· 2 shared E. Assenat· 2 shared A. Camasses· 1 shared A. Polizzi· 1 shared

Activity by Year

2019-2023 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 28 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

4 shared papersCancer Biology

D. Gregoire

Mutual co-authors in cluster

Author profile →

5 papers

Recent·Most cited

FGF19 and its analog Aldafermin cooperate with MYC to induce aggressive hepatocarcinogenesis

J. Ursic-Bedoya, G. Desandre, C. Chavey, P. Marie, A. Polizzi, B. Riviere, H. Guillou, E. Assenat, U. Hibner, D. Gregoire

This study shows that FGF19 and its analog Aldafermin cooperate with MYC to drive aggressive hepatocarcinogenesis in mice, raising concerns about the safety of Aldafermin in patients with compromised livers.

bioRxiv · Sep 15, 2023Cancer Biology

The hormone Fibroblast Growth Factor 19 stimulates water intake

J. Ursic-Bedoya, C. Chavey, L. Meunier, G. Desandre, A.-M. Dupuy, I. Gonzalez-Dopeso Reyes, T. Tordjmann, E. Assenat, U. Hibner, D. Gregoire

This study identifies FGF19 as a stimulator of water intake in mice, with implications for its role in cancer and metabolic disorders.

bioRxiv · Oct 26, 2021 · PreprintPhysiology

Ras/MAPK signalling intensity defines subclonal fitness in a mouse model of primary and metastatic hepatocellular carcinoma

A. Lozano, F.-R. Souche, C. Ramirez, S. Vegna, G. Desandre, A. Riviere, V. Dardalhon, A. Zine El Aabidine, P. Fort, L. Akkari, U. Hibner, D. Gregoire

This study shows that varying levels of MAPK Erk signaling in Ras-transformed cells influence tumor growth and immune evasion in a mouse model of hepatocellular carcinoma.

bioRxiv · Aug 13, 2021Cancer Biology

Paracrine behaviors arbitrate parasite-like interactions between tumor subclones

R. J. Noble, V. Walther, C. Roumestand, U. Hibner, M. E. Hochberg, P. Lassus

The paper shows that in vitro, one tumor subclone benefits from the presence of another by farming it through paracrine metabolites, enhancing its growth while reducing the loser's growth.

bioRxiv · Dec 14, 2020Cancer Biology

CDK8 and CDK19 kinases have non-redundant oncogenic functions in hepatocellular carcinoma

K. Bacevic, S. Prieto, S. Caruso, A. Camasses, G. Dubra, J. Ursic-Bedoya, A. Lozano, J. Butterworth, J. Zucman-rossi, U. Hibner, D. Fisher, D. Gregoire

The paper investigates the roles of CDK8 and CDK19 in hepatocellular carcinoma, finding they are overexpressed and have non-redundant oncogenic functions that interact with TP53.

bioRxiv · Oct 1, 2019 · PreprintCancer Biology